Champions Oncology
Contract research organization (CRO) · Baltimore, Maryland, United States · Nasdaq: CSBR
Champions Oncology is a contract research organization (CRO) headquartered in Baltimore, Maryland, United States. Its shares trade on Nasdaq under the ticker CSBR. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2015.
Champions Oncology at a glance
What does Champions Oncology do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2017).
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $14 million sold (2015).
Champions Oncology on the BioBridgeX marketplace
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Assay Development & Screening
Services
Therapeutic areas
Modalities
Unclaimed listing. Claim this profile
Frequently asked questions about Champions Oncology
Where is Champions Oncology headquartered?
Champions Oncology is headquartered in Baltimore, Maryland, United States.
What does Champions Oncology do?
Champions Oncology is a contract research organization (CRO). Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Champions Oncology a public company?
Yes. Champions Oncology trades on Nasdaq under the ticker CSBR.
Similar companies
- Twist BioscienceSouth San Francisco, California, United States
- InotivWest Lafayette, Indiana, United States
- CertaraRadnor, Pennsylvania, United States
- Reaction BiologyMalvern, Pennsylvania, United States
- Charles River LaboratoriesWilmington, Massachusetts, United States
- Simulations PlusLancaster, California, United States
- Crown BioscienceSanta Clara, California, United States
- CytelSan Diego, California, United States
Sources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.